Research Article
The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
Table 2
Specific ACE/ARB’s used by expose subjects.
| | Count (%) |
| Ramipril | 38 (27.5%) | Lisinopril | 25 (18.1%) | Enalapril | 15 (10.9%) | Monopril | 8 (5.8%) | Valsartan | 8 (5.8%) | Perindopril | 7 (5.1%) | Candesartan | 6 (4.3%) | Irbesartan | 6 (4.3%) | Losartan | 5 (3.6%) | Quinapril | 5 (3.6%) | Cilazapril | 3 (2.2%) | Fosinopril | 3 (2.2%) | Telmisartan | 3 (2.2%) | Captopril | 2 (1.4%) | Prinivil | 1 (0.7%) | Trandolapril | 1 (0.7%) | Polytherapy | 2 (1.4%) |
|
|